Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has issued an update.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license at a store in Andhra Pradesh. This suspension, issued by the District Sales Licensing Authority, is due to violations under the Drugs and Cosmetics Act, 1940, and is expected to result in a potential revenue loss of approximately Rs 0.62 Lacs for the company.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on the retail pharmacy sector. The company provides a wide range of pharmaceutical products and health-related services, catering to consumers across India.
YTD Price Performance: -5.62%
Average Trading Volume: 4,918
Current Market Cap: 95.86B INR
For a thorough assessment of MEDPLUS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money